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Hansen and Clausen have suggested that poor sarcolemmal 
recovery, based upon measurements of Na,K-ATPase activity, 
may lead to misconceptions concerning the constituents of 
muscle membranes and possible changes with experimental 
manipulation. In their argument hey cite a recent paper in 
which we investigated whether the GLUT4 glucose transpor- 
ter and the ct2-Na,K-ATPase subunit could be colocalised 
within membranes of intracellular origin. The major finding 
produced was that GLUT4 and the ct2-Na,K-ATPase subunit 
were not in fact colocalised, according to the observation that 
membranes containing these proteins had different sedimenta- 
tion properties; furthermore, GLUT4-containing vesicles, iso- 
lated by immunoprecipitation from an intracellular muscle 
fraction, were devoid of both the ~2- and 131-subunits of the 
Na,K-ATPase [1]. The work did not study translocation of 
Na,K-ATPase and GLUT4 between subcellular membrane 
fractions nor did it involve the fraction termed the plasma 
membrane, despite the impression given in the letter by Han- 
sen and Clausen. Nevertheless, the issue of sarcolemmal re- 
covery is an important one and the comments these corre- 
spondents made have important implications for those with 
an interest in muscle physiology and biochemistry; they there- 
fore deserve discussion and further clarification. 
A few points need to be emphasized regarding the data 
concerning isolated membrane fractions and its comparison 
with that obtained from intact tissues and also about the 
method used to assess recoveries of the sarcolemma. First, 
the membrane pellet KpNPPase activities hown in Table 1 
of our paper [1] are those obtained from membranes pelleted 
at the bottom of the sucrose gradient and not in the crude 
homogenate. The enrichments hown were calculated with 
respect o the enzymatic activity in crude membranes (for 
which the data was not shown). If the sarcolemmal recovery 
is calculated based on the activities normally obtained in the 
homogenate, then it is about 1.6%. Secondly, the fractionation 
procedure we used leads to recovery of membranes enriched 
with sarcolemma but without any significant amounts of 
transverse-tubular (TT) membranes (based on the lack of re- 
activity with antibodies to TT membrane markers, e.g. the 
dihydropyridine receptor) [2]. The ouabain-binding data 
from intact muscle will reflect association of the glycoside to 
c~-subunits on both the sarcolemma and the TT. Since the TT 
membranes constitute nearly 60-70% of the total muscle sur- 
face area [3] and also house a sizable pool of immunoreactive 
Na,K-ATPase tx-subunits [2] their absence from our sarcolem- 
mal fraction would imply that comparison of the amount of 
ATPase (based on data from this fraction alone) with that of 
intact tissue is not appropriate. Thirdly, we are in total agree- 
ment with Hansen and Clausen that the recovery of muscle 
Na,K-ATPase activity, in what is termed the plasma mem- 
brane fraction, from a number of studies is small, ranging 
between 0.2 and 8.9% (reviewed in [4]). The precise reason 
for this remains poorly understood but in biochemistry it is 
generally accepted that whenever one attempts to purify mem- 
branes to a high degree the final yield is always compromised 
and this is ever more patent for muscle which is full of cyto- 
plasmic proteins. Furthermore, the suggestion that K+-depen - 
dent phosphatase activity is susceptible to chemical reagents 
and physical treatments [5] may imply that measurement of its 
activity in isolated membrane fractions for calculation of re- 
covery is not entirely satisfactory. This proposition is sup- 
ported by a recent study [6] in which enzymatic recoveries 
were compared with those of immunological markers of the 
sarcolemma. Dombrowski et al. found that their sarcolemmal 
recoveries of 5'-nucleotidase and K+-stimulated phosphatase 
activity, relative to the starting muscle homogenate, were 5 
and 8% respectively [6]. These recoveries are within the range 
of reported values [4]. However, if the recoveries were calcu- 
lated based upon immunological markers of the sarcolemma, 
such as the cq-subunit of the Na,K-ATPase or the GLUT1 
glucose transporter [7], then it was significantly high- 
er (,,~ 15%) [6]; we have carried out similar analyses on 
our sarcolemmal fraction and obtain recoveries of a similar 
order of magnitude. This approach may be useful since it 
overcomes difficulties related to structural integrity, mem- 
brane orientation or loss, through inactivation, of enzymatic 
activity. 
Accepting the limitations with regard to the use of enzy- 
matic activities for calculation of sarcolemmal recoveries the 
central question remains: how representative is this enriched 
membrane fraction of the total sarcolemma nd can studies 
with it yield meaningful data about sarcolemmal components? 
In our opinion there are several lines of evidence supporting 
the view that, despite the relatively low yield of this fraction, it 
does provide useful information about membrane proteins. 
Some of this evidence, relating to work concerning lucose 
transporters and the Na,K-ATPase, is discussed below. 
First, immunological analyses of muscle membrane frac- 
tions with antibodies against GLUT1 and the GLUT5 hexose 
transporters eveals that both proteins are predominantly ex- 
pressed in the fraction termed the plasma membrane [7,8] This 
finding is consistent with morphological studies carried out at 
both the light and electron microscopic level which show that 
both transporters are exclusively confined to the sarcolemma 
[7-9]. Moreover, it is noteworthy that the human GLUT5 
transporter is not expressed in neural, vascular or connective 
tissue and thus its observed immunoreactivity in the human 
sarcolemmal fraction (observed using two distinct fractiona- 
S0014-5793/96l$12.00 © 1996 Federation of European Biochemical Societies. All rights reserved. 
SSDIS0014-5793(96)00306-7  
H.S. Hundal, J.C Aledo/FEBS Letters 384 (1996) 204-205 
tion protocols, [8]) is unlikely to have arisen from sources 
other than the sarcolemma. 
Secondly, data from a number of different laboratories, 
using different fractionation methods which all suffer from 
problems of low sarcolemmal yield, are qualitatively very si- 
milar with regard to the insulin-induced recruitment of 
GLUT4 from intracellular membrane stores to the sarcolem- 
ma [2,10-14]. The increased GLUT4 recovery in the sarcolem- 
mal fraction is not a generalised response since within the 
same fraction there are no detectable changes in the abun- 
dance of proteins such as GLUT1 [7], the al-subunit of the 
Na,K-ATPase [2,15] or 131-integrin [13]. The redistribution of 
GLUT4 to the sarcolemma in response to insulin is consistent 
with that observed in adipocytes, which afford much higher 
recoveries of the plasma membrane [16]. Moreover, in our 
opinion, the increased GLUT4 abundance in the sarcolemmal 
fraction is likely to be representative of changes in the sarco- 
lemma as a whole, based on observations showing that insulin 
treatment results in a marked increase in the number of glu- 
cose transporters at the cell surface of intact soleus muscles as 
judged using the exo-facial ATB-[2-3H]BMPA photolabel [17]. 
Thirdly, insulin also stimulates the subcellular edistribu- 
tion of the ct2- and 131-subunits of the Na,K-ATPase in ske- 
letal muscle [15]. This effect is specific for these two isoforms 
as the hormone does not affect the sarcolemmal bundance of 
the txl- and 132-Na,K-ATPase subunits [15]. This observation 
is not an artefact introduced by contaminating non-muscle 
cell types since electronmicroscopy, using monoclonal and 
polyclonal antibodies to the ct2-subunit, shows (a) significant 
intramuscular labelling of the tx2-subunit and (b) that insulin 
induces a significant increase in the number of immunogold 
particles (i.e. tx2-subunits) at the muscle surface [18]. 
One final piece of evidence which we wish to draw attention 
to concerns the finding that sarcolemmal fractions prepared 
from red or white muscle display distinct immunoreactivity 
patterns for the [31 and 132-subunit isoforms. The 131, but not 
the 132, subunit is only detectable in fractions prepared from 
red (slow-oxidative, Type I) muscles, whereas, only 132 is de- 
tected in fractions prepared from white (fast-glycolytic, Type 
lib) muscles [19]. It is difficult to attribute such findings to 
contamination of the sarcolemma by membranes of non-mus- 
cle origin which are unlikely to be separated in a muscle type- 
specific manner. Our protein data were also mirrored by dis- 
tribution of RNA transcripts for these two 13-isoforms in the 
different muscle types [19]. Such information ot only under- 
scores the muscle type-specific expression of 13-subunit iso- 
forms but strengthens the suggestion that information gleaned 
from studies using the sarcolemmal fraction is meaningful. 
Indeed, the biochemical observations made in isolated mem- 
branes have now been confirmed by immuno electron micro- 
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scopy, demonstrating that 13-subunits are differentially ex- 
pressed in muscles of different fibre type, and that insulin 
induces 131 redistribution [20]. 
The problem of poor sarcolemmal recovery from skeletal 
muscle is widely recognised and most investigators accept hat 
the limitations of the isolation procedure make it far from 
perfect. Nevertheless a substantial amount of evidence has 
now accumulated clearly indicating that analyses of the sar- 
colemmal fraction have made major contributions to impor- 
tant new discoveries regarding sarcolemmal composition 
[8,19] and the dynamics of physiological membrane processes 
[2,11,15]. 
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